{
  "slug": "biotelemetry-acquired-by-philips",
  "name": "biotelemetry-acquired-by-philips",
  "description": "BioTelemetry develops diagnostics and monitors for heart rhythm disorders, including wearable heart monitors that detect and transmit abnormal heart rhythms wirelessly, along with AI-based data analytics and services.",
  "url": "https://optimly.ai/brand/biotelemetry-acquired-by-philips",
  "websiteUrl": "https://massdevice.com/",
  "logoUrl": "https://logo.clearbit.com/massdevice.com",
  "baiScore": 29,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": "Incumbent",
  "archetype_status": "active",
  "category": "Healthcare Technology",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-08-10T02:55:03.416Z",
  "verifiedVitals": {
    "website": "https://massdevice.com",
    "headquarters": "Not explicitly stated in the provided text, but acquired by Amsterdam-based Philips.",
    "pricing_model": "Not specified in the text, but likely B2B (business-to-business) or service-based subscriptions for monitoring and diagnostics provided to healthcare systems or directly to patients through medical prescription.",
    "core_products": "Diagnostics and monitors for heart rhythm disorders, wearable heart monitors, AI-based data analytics and services for cardiac care.",
    "key_differentiator": "Advanced wearable heart monitors with wireless data transmission combined with AI-based data analytics for detecting and analyzing abnormal heart rhythms.",
    "target_markets": "Patients with heart rhythm disorders, healthcare providers, and the broader connected care segment.",
    "employee_count": "Approximately 1,900",
    "funding_stage": "Acquired by Royal Philips for $2.8 billion (February 2021).",
    "subcategory": "Remote Patient Monitoring, Cardiac Diagnostics"
  },
  "intentTags": {
    "problemIntents": [
      "Diagnosing heart rhythm disorders",
      "Need for continuous cardiac monitoring",
      "Inefficiency of traditional cardiac diagnostics"
    ],
    "solutionIntents": [
      "Remote cardiac monitoring solutions",
      "Wearable heart monitors with wireless capabilities",
      "AI-based data analytics for cardiac care",
      "Connected care business expansion"
    ],
    "evaluationIntents": [
      "Assessing acquisition value and terms",
      "Evaluating market impact of strategic acquisitions",
      "Analyzing potential for sales growth and EBITA margin improvement",
      "Reviewing integration of acquired companies into larger entities"
    ]
  },
  "timestamp": 1786464140183
}